CV Shariat_AKH - Vienna OMI

• Nature Clinical Practice Oncology 11/2007 – present• Expert Opinion on Therapeutic Targets 11/2007 – present• Asian Journal of Andrology 11/2007 – present• Current Opinion in Molecular Therapeutics 12/2007 – present• Expert Review of Proteomics 1/2008 – present• Expert Opinion on Medical Diagnostics 2/2008 – present• World Journal of Urology 3/2008 – present• Laboratory Investigation 4/2008 – present• Radiotherapy and Oncology 6/2008 – present• Cancer Treatment Review 8/2008 – present• BioMed Central Cancer 1/2009 – present• Annals of Oncology 3/2009 – present• International Journal of Urology 3/2009 – present• Lancet Oncology 7/2009 – present• The Journal of Sexual Medicine 8/2009 – present• The Prostate 9/2009 – present• Molecular Cancer Therapeutics 10/2009 – present• Nature Reviews Clinical Oncology 11/2009 – present• Cancer Epidemiology, Biomarkers and Prevention 3/2010 – present• International Journal of Surgery 3/2010 – present• Expert Opinion on Investigational Drugs 4/2010 – present• Tumor Biology - The International Society of Oncology and BioMarkers 5/2010 – present• Critical Reviews in Oncology/Hematology 6/2010 – present• The Journal of Proteome Research 6/2010 – present• Cancer Treatment Reviews 9/2010 – present• Molecular Medicine 11/2010 – present• Journal of Endourology 11/2010 – presentV I S I T I N G P R O F E S S O R S H I P S• Visiting Professor, University of Montreal, Montreal, Quebec, Canada 9/2008The benefits of early androgen blockade;Urologic trauma: experience at Parkland Memorial Hospital;Potential effect of testosterone supplements of prostate cancer biology• Visiting Professor, XXV Jornadas Urologicas De La Filial Sur de la Sociedad 8/2010Chilena de Urología. 13-15 Agosto 2010, Temuco, Chile.Cancer Vesical Sin Invasion MuscularRole of surgery in invasive and advanced bladder cancerPerioperative chemotherapy for muscle invasive bladder cancerUrine biomarkers for bladder cancer detection and surveillance• Visiting Professor, Sociedad Chilena de Urologia, Santiago de Chile, Chile 8/2010Update on non-muscle invasive bladder cancerCytoreductive nephrectomy in the era of targeted molecular agents: is it time to considerpre-surgical therapy?• Visiting Professor, Department of Urology, University of Hamburg, Hamburg, Germany 11/2010Evidence-based management of non-muscle invasive bladder cancer (11/3/2010)Martini Prostate Kli nik, University of Hamburg, Hamburg, GermanyDisease state-specific integration of biomarkers for prostate cancer (11/4/2010)• Visiting Professor, Div. of Urology, Maimonides Medical Center, Brooklyn, NY, USA4/16/2012www.vienna-omi.at 28.08.2013